[ad_1]
Dyadic International Inc. Chairman (NASDAQ: DYAI), Michael Tarnok, told Proactive Investors that he was very impressed with the nine collaborations created by Dyadic in 2018.
In particular, former Pfizer sales and marketing manager (NYSE: PFE) is focusing on the latest collaboration announced by Dyadic with vaccine and immuno-biological manufacturer Serum Institute of India.
Source link
